United Kingdom

India's Alembic Pharma Sept-qtr consol PAT rises

Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Alembic Pharmaceuticals Ltd ::Says U.S. formulations business continues to face price erosion on some key products; India branded business showing signs of recovery‍​‍​.Sept quarter consol PAT 1.22 billion rupees versus 1.20 billion rupees year ago.Sept quarter consol revenue from operations 7.89 billion rupees versus 8.79 billion rupees year ago.